Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Nora Liebers, Johannes Duell, Donnacha Fitzgerald, Andrea Kerkhoff, Daniel Noerenberg, Eva Kaebisch, Fabian Acker, Stephan Fuhrmann, Corinna Leng, Manfred Welslau, Jens Chemnitz, Jan-Moritz Middeke, Thomas Weber, Udo Holtick, Ralf Trappe, Roald Pfannes, Ruediger Liersch, Christian Spoer, Stefan Fuxius, Niklas Gebauer, Léandra Caillé, Thomas Geer, Christian Koenecke, Ulrich Keller, Rainer ClausGND, Dimitrios Mougiakakos, Stephanie Mayer, Andreas Huettmann, Christiane Pott, Arne Trummer, Gerald Wulf, Uta Brunnberg, Lars Bullinger, Georg Hess, Carsten Mueller-Tidow, Bertram Glass, Georg Lenz, Peter Dreger, Sascha Dietrich
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/87946
URL:http://ashpublications.org/bloodadvances/article-pdf/5/13/2707/1811181/advancesadv2020004155.pdf
ISSN:2473-9529OPAC
ISSN:2473-9537OPAC
Parent Title (English):Blood Advances
Publisher:American Society of Hematology
Type:Article
Language:English
Year of first Publication:2021
Release Date:2021/09/15
Volume:5
Issue:13
First Page:2707
Last Page:2716
DOI:https://doi.org/10.1182/bloodadvances.2020004155
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Professur für personalisierte Tumormedizin und molekulare Onkologie